This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/06/16 - 11:08:06 AM ET (BATS BZX Real-time Price)
Div Yield: --
MYGN Day's Range
MYGN 52 Week Range
MYGN Business Summary
Myriad Genetics, Inc., a personalized medicine company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide.View MYGN
Myriad Genetics Inc - MYGN - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Myriad Genetics Inc as a
Buy with a ratings score of B.
Report Snippet: We rate MYRIAD GENETICS INC (MYGN) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.